Aires Pharmaceuticals, Inc.   Report issue

Contributed to NME For profit Phase 2
Founded: San Diego California United States (2006)
Status: Acquired by Mast Therapeutics (2014) → now Savara Inc. (2017)

Organization Overview

First Clinical Trial
2008
NCT00814645
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2016

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Active Ingredients

Drugs in Phase 2 Trials (1)

sodium nitrite (7 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Familial Primary Pulmonary Hypertension (Phase 2)

Heart Failure (Phase 2)

Hypertension (Phase 2)

Hypertension, Pulmonary (Phase 1)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 7
  • # of Trial APIs: 1